Secondly, to put things in perspective, less than 10 patients have chosen to be treated on the ossatron pimarily because of heelspurs.com. Additionally, Healthtronics has no financial interest in the canadian site. If they treat a thousand patients a day we would not benefit. I happen to know that the canadian customer as of yet is not profitable providing this service. The Canadian government does not reimburse for this service and the stream of patients from the us is up til now minimal. Dr. Galea does not want to aggressively advertise until he has an adequate track record with our product. Also, for each patient that we treat in the fda studies, we lose thousands of dollars tracking and reporting the outcome. The only money we earn as a company deals with selling the already fda approved kidney lithotripter.
Heelspurs.com provides us with an invaluable service - it reminds us on a daily basis why we are spending millions of dollars seeking fda approval - to make a difference in the lives of millions of pf sufferers who have not been well served by technology and the healthcare community. Oddly enough, it is our goal to put this website out of business since we hope to eliminate chronic pf suffering. Wish us luck. In the meantime, we wish you luck and hope that one of the hundreds of recommendations found on this site provides relief.